| Metric | FY 2026↕ | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|---|
| Revenue | $4.9B | $4.7B | $4.5B | $4.4B | $4.1B | $0.9B | $0.2B |
| Cost of Revenue | $1.1B | $1.1B | $1.1B | $1.1B | $1.1B | $0.8B | $0.1B |
| Gross Profit | $3.7B | $3.5B | $3.4B | $3.3B | $3.0B | $0.6B | $0.2B |
| R&D Expense | $0.8B | $0.9B | $0.8B | $0.8B | $0.4B | $0.2B | $0.1B |
| SG&A Expense | — | — | — | — | — | — | — |
| Operating Income | $1.1B | $0.8B | $0.5B | $0.2B | $1.1B | $0.3B | $0.0B |
| Net Income | $1.9B | $1.0B | $0.6B | $0.1B | $1.4B | $0.7B | $0.0B |
| EPS (Basic) | $6.32 | $3.28 | $2.12 | $0.35 | $4.64 | $0.91 | $0.06 |
| EPS (Diluted) | $6.18 | $3.21 | $2.07 | $0.34 | $4.50 | $0.87 | $0.05 |
| Metric | FY 2026↕ | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|---|
| Total Assets | $12.0B | $11.0B | $9.9B | $8.1B | $7.6B | $5.3B | $1.3B |
| Current Assets | $8.7B | $8.7B | $7.9B | $6.4B | $6.2B | $4.8B | $1.1B |
| Cash & Equivalents | $1.3B | $1.3B | $1.6B | $1.1B | $1.1B | $2.2B | $0.3B |
| Total Liabilities | $2.2B | $2.1B | $1.9B | $1.9B | $1.8B | $1.4B | $0.5B |
| Current Liabilities | $2.0B | $1.9B | $1.8B | $1.7B | $1.6B | $1.3B | $0.3B |
| Stockholders' Equity | $9.8B | $8.9B | $8.0B | $6.2B | $5.8B | $3.9B | $0.8B |
| Metric | FY 2026↕ | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.0B | $1.9B | $1.6B | $1.3B | $1.6B | $1.5B | $0.2B |
| Investing Cash Flow | $-0.3B | $-1.1B | $-1.2B | $-0.3B | $-2.9B | $-1.6B | $-0.5B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B |
| Financing Cash Flow | $-1.8B | $-1.0B | $0.1B | $-0.9B | $0.0B | $2.1B | $0.6B |